default author photo

Joon Oh Park

Sungkyunkwan University - Department of Medicine

53 Myeongnyun-dong 3-ga Jongno-ju

Guro-gu

Seoul, 110-745

United States

  • Sungkyunkwan University - Department of Medicine

SCHOLARLY PAPERS

4

DOWNLOADS

337

TOTAL CITATIONS

2

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer after Preoperative Chemoradiotherapy (ADORE): Long-Term Results of an Open-Label, Multicentre, Phase 2, Randomised Controlled Trial

Number of pages: 78 Posted: 08 Jan 2019
Yong Sang Hong, Sun Young Kim, Ji-Sung Lee, Byung-Ho Nam, Kyu-pyo Kim, Jeong Eun Kim, Young Suk Park, Joon Oh Park, Ji Yeon Baek, Tae-You Kim, Keun-Wook Lee, Joong Bae Ahn, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim, Seong Hyeon Yun, Jong Hoon Kim, Jin-hong Park, Hee Chul Park, Kyung Hae Jung and Tae Won Kim
University of Ulsan, University of Ulsan, University of Ulsan, College of Medicine, Asan Medical Center, Clinical Research Center, Institute of Advanced Clinical and Biomedical Research, University of Ulsan - Department of Oncology, University of Ulsan, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Department of Medicine, National Cancer Center, Korea, Seoul National University - College of Medicine, Seoul National University - Department of Internal Medicine, Yonsei University, University of Ulsan, University of Ulsan, University of Ulsan, Sungkyunkwan University, University of Ulsan, University of Ulsan, Sungkyunkwan University, University of Ulsan - Department of Oncology and University of Ulsan - Department of Oncology
Downloads 162 (461,984)
Citation 1

Abstract:

Loading...

adjuvant chemotherapy; FOLFOX; 5-FU; rectal cancer; preoperative chemoradiotherapy

2.

Genomic Characterization of Intrinsic and Acquired Resistance to Cetuximab in Colorectal Cancer Patients

Number of pages: 34 Posted: 04 Jan 2019
Steven M Bray, Jeeyun Lee, Seung Tae Kim, Sun Young Kim, Joon Young Hur, Philip J Ebert, John N Calley, Isabella H Wulur, Thejaswini Gopalappa, Swee Seong Wong, Hui-Rong Qian, Jason C Ting, Jiangang Liu, Melinda D Willard, Ruslan D Novosiadly, Young Suk Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Amit Aggarwal, Hee Cheol Kim and Christoph Reinhard
Eli Lilly and Company, Ltd, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - School of Medicine, Sungkyunkwan University, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Eli Lilly and Company, Ltd, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - School of Medicine, Eli Lilly and Company, Ltd, Sungkyunkwan University - Department of Surgery and Eli Lilly and Company, Ltd - Oncology Discovery Research
Downloads 70 (875,328)

Abstract:

Loading...

Cetuximab, Acquired Resistance, Colorectal Cancer

3.

Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Randomized, Phase Three, Non-Inferiority Trial

Number of pages: 60 Posted: 09 Aug 2018
Seung Tae Kim, Jung Hun Kang, Jeeyun Lee, Hyun Woo Lee, Sung Young Oh, Joung Soon Jang, Myung Ah Lee, Byeong Seok Sohn, So Young Yoon, Hye Jin Choi, Ji Hyong Hong, Min-Ji Kim, Min-Ji Kim, Seonwoo Kim, Young Suk Park, Joon Oh Park and Ho Yeong Lim
Sungkyunkwan University - Department of Medicine, Gyeongsang National University - Department of Medicine, Sungkyunkwan University - Division of Hematology-Oncology, Ajou University - Department of Medicine, Dong-A University - Department of Medicine, Chung-Ang University, College of Medicine, Department of Medicine, Catholic University of Korea - Department of Medicine, Inje University - Department of Medicine, Konkuk University - Department of Medicine, Yonsei University - Department of Medicine, Catholic University of Korea - Department of Medicine, Sungkyunkwan University - Statistics and Data CenterSungkyunkwan University - Department of Ophthalmology, Sungkyunkwan University - Statistics and Data Center, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Department of Medicine and Sungkyunkwan University - Department of Medicine
Downloads 55 (1,020,567)
Citation 1

Abstract:

Loading...

biliary tract cancer, capecitabine, oxaliplatin, gemcitabine

4.

Systematic Evaluation of Tumor Cell Index and Two-Drug Combination Therapy via 3-Dimensional High-Throughput Drug Screening

Number of pages: 23 Posted: 22 Aug 2019
Sung Hee Lim, Jason K. Sa, Jusun Kim, Dong Woo Lee, Seung Tae Kim, Se Hoon Park, Bosung Ku, Joon Oh Park, Young Suk Park, Hoyeong Lim, Won Ki Kang, Do-Hyun Nam and Jeeyun Lee
Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Institute for Refractory Cancer Research, Sungkyunkwan University - Division of Hematology-Oncology, Medical & Bio Device (MBD) Co., Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Division of Hematology-Oncology, Medical & Bio Device (MBD) Co., Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - School of Medicine, Sungkyunkwan University - Institute for Refractory Cancer Research and Sungkyunkwan University - Division of Hematology-Oncology
Downloads 50 (1,063,489)

Abstract:

Loading...

Tumour heterogeneity; Tumour purity; Patient-derived tumour cell; High-throughput drug screening; Two-drug combination